Antidepressants and Vulvodynia
Third Newsletter from the First Latin American Men's Health Forum Now Available
Antidepressants are a common treatment strategy for women with vulvodynia, but a recent study published in the Journal of Sexual Medicine suggests that more research is needed.
Women with vulvodynia feel persistent pain or discomfort in the vulva. They may feel stinging, itching, and burning. Often, there is no clear cause.
In a literature review, researchers from the State University of New York at Buffalo School of Medicine and Biomedical Sciences analyzed the types of antidepressants used for vulvodynia, the doses, the duration treatment, side effects, and the effect of any accompanying health conditions.
They found that there has not been enough solid research on the subject. “The results of this review indicate that there is a dearth of well-designed studies and inconsistent findings across investigations for the utility of antidepressant pharmacotherapy in the treatment of vulvodynia,” they wrote.
Click here to learn more about this study.
World Meeting Take Home Messages: Peyronie's Disease
The third newsletter from the First Latin American Men's Health Forum, held in March in Cancun, Mexico, is now available on the ISSM website. This newsletter focuses on prostate cancer treatment and sexual dysfuntion, with articles on communication and education, routine PSA screening, PSA testing after BPH therapy, and two common viruses that have been linked to prostate cancer. To read these articles and learn more about the forum, please click here.
Each week, ISSM Update has been bringing you take home messages from the World Meeting on Sexual Medicine held in Chicago in August. In this issue, we focus on Peyronie's Disease (PD). Dr. Juan Ignacio Martínez-Salamanca of Spain prepared this presentation which looks at basic research, diagnosis and evaluation, PD relationships, and medical/surgical treatment.
Please click here to see the entire list of take home messages from the World Meeting.